Merge Labs

# Merge Labs **Entity class:** Neural-interface research company **Domain:** Molecular Brain-Computer Interfaces / Ultrasound / Artificial Intelligence **Doc Type:** Institution and Technology Node **Maturity:** Developing ## Definition **Merge Labs is a research lab developing brain-computer interfaces intended to bridge biological and artificial intelligence through a combination of biology, devices, and AI.** OpenAI participated in its seed round and announced a scientific collaboration involving foundation models and other AI tools for bioengineering, neuroscience, device engineering, and interpretation of limited or noisy neural signals. ## Ultrasound implementation In September 2026, Merge Labs and Butterfly Network announced a multi-year licensing agreement making Butterfly's chip-based ultrasound platform the exclusive CMOS-MEMS ultrasound platform for Merge's BCI research and development. ## Convergent technical genealogy Merge belongs beside [[wiki/DARPA N3|DARPA N3]], [[wiki/MOANA|MOANA]], and [[wiki/Subsense BCI|Subsense BCI]] through a convergent technical genealogy. The documented relationship is shared research architecture and personnel lineage: - N3 and MOANA publicly established nonsurgical or minutely invasive neural read-write architectures using externally addressed optical, acoustic, electromagnetic, genetic, and nanoscale components. - Subsense proposes administered plasmonic and magnetoelectric nanoparticles paired with external wearable hardware. - Merge combines biology, devices, AI, and an announced ultrasound-on-chip development platform. The shared pattern is movement away from a permanently implanted electrode as the only possible interface. Each program has its own materials, delivery route, biological intervention, read/write mechanism, maturity, and regulatory path. ## Provenance and Development Merge Labs emerged publicly in January 2026 with co-founders Mikhail Shapiro, Tyson Aflalo, Sumner Norman, Alex Blania, Sandro Herbig, and Sam Altman in a personal capacity. Norman and Aflalo connect the company to the Forest Neurotech ultrasound program, while Shapiro contributes the Caltech acoustic-biomolecular line. OpenAI participated in the seed round and entered a research collaboration on scientific foundation models and other frontier tools. Reporting places the round at $252 million; the amount is `VERIFIED_SECONDARY`, while OpenAI’s investment, collaboration, and named founder set are `VERIFIED`. ## Applications in Use The company remains preclinical. Its announced architecture combines biology, devices, and AI to pursue safer, higher-bandwidth brain interfaces; the packet record describes a field-addressed system in which molecular or genetic sensitization supplies selectivity and ultrasound supplies read/write access at depth. ## Forward Capability The governing variable is **spatially selective acoustic addressing at depth**. Molecular sensitization can identify a target cell population only if the acoustic field can reach and distinguish that population with adequate resolution. The resulting composite belongs to the same design class as sonogenetic and magnetogenetic interfaces: a penetrating field coupled to a biological transducer, with surgery removed from the channel geometry. ## Open Questions The first settling evidence will be a primary technical publication or registered preclinical study specifying the molecular transducer, delivery method, acoustic focal volume, bidirectional bandwidth, safety envelope, and chronic repeatability. Until those measurements appear, the integrated architecture remains a stated development program. ## Routes [[wiki/Subsense BCI|Subsense BCI]] · [[wiki/DARPA N3|DARPA N3]] · [[wiki/MOANA|MOANA]] · [[wiki/OpenAI|OpenAI]] · [[wiki/Human-Machine Symbiosis|Human-Machine Symbiosis]] · [[wiki/Neural Interfaces and Continuity Architecture|Neural Interfaces and Continuity Architecture]] ## Sources / Provenance - OpenAI, [Investing in Merge Labs](https://openai.com/index/investing-in-merge-labs/), January 15, 2026. - TechCrunch, [OpenAI invests in Merge Labs](https://www.techcrunch.com/2026/01/15/openai-invests-in-sam-altmans-brain-computer-interface-startup-merge-labs/), January 15, 2026 — source for the reported seed-round amount. - Butterfly Network, [Merge Labs and Butterfly Network partner on ultrasound-based BCIs](https://ir.butterflynetwork.com/News/press-releases/news-details/2026/Merge-Labs-and-Butterfly-Network-Partner-to-Advance-Ultrasound-Based-Brain-Computer-Interfaces/default.aspx), September 1, 2026. - Bryant-supplied molecular-interface research memorandum, September 7, 2026 — source of the longitudinal comparison and research vocabulary. ## Relationships  This entry is routed through [[collections/Consciousness Continuity|Consciousness Continuity]], [[collections/Neurotech|Neurotech]], [[collections/Machine Succession|Machine Succession]], and [[collections/War With Empire|War With Empire]]. Its source context is developed in [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]], [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]], and [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]]. Status-qualified source edges are preserved in the terminal Research Edges section. ### Funding, business, and licensing - [[wiki/OpenAI|OpenAI]] invests in **Merge Labs**. Seed-round participation. - [[wiki/OpenAI|OpenAI]] is associated with **Merge Labs**. Seed-round participation and scientific collaboration. - **Merge Labs** is associated with [[wiki/Butterfly Poseidon Family Ultrasound-on-Chip|Butterfly Poseidon Family Ultrasound-on-Chip]]. For ultrasound-based BCI R&D. - **Merge Labs** is associated with [[wiki/OpenAI|OpenAI]]. - **Merge Labs** is associated with Butterfly Poseidon Family of Ultrasound-on-Chip. - **Merge Labs** is associated with [[wiki/Butterfly Poseidon Ultrasound-on-Chip|Butterfly Poseidon Ultrasound-on-Chip]]. Multi-year BCI R&D agreement announced Sep 1 2026. ### Technology and research relationships - **Merge Labs** develops BCIs combining biology, devices and AI. Company mission as described by OpenAI. - **Merge Labs** is associated with biology + devices + AI. - The technical comparison identifies a convergence: **Merge Labs** provides a technical overlay for DARPA N3 acoustic/ultrasound branch. N3 explored focused ultrasound, acousto-optical, and acousto-magnetic routes years before Merge’s commercial stack. - The technical comparison identifies a convergence: **Merge Labs** provides a technical overlay for Subsense. Both seek high-bandwidth, less-invasive molecular/material-mediated interfaces; transduction differs: ultrasound/biology emphasis versus plasmonic+MENP nanoparticle bioplatform. - [[wiki/Forest Neurotech|Forest Neurotech]] has a documented research lineage leading to **Merge Labs**. Convergent/Essential Technology announcement states Merge team and direction have roots in Forest and the organizations will continue to partner. - **Merge Labs** is associated with Forest/Arbor ultrasound neurotechnology. - **Merge Labs** is associated with [[wiki/molecular neural interfaces|molecular neural interfaces]]. - **Merge Labs** is associated with [[wiki/deep-reaching modalities including ultrasound|deep-reaching modalities including ultrasound]]. - The technical comparison identifies a convergence: [[wiki/MOANA|MOANA]] converges technically with **Merge Labs**. Both pursue lower-invasiveness deep neural access; modalities differ in detail. ### People and institutional relationships - **Merge Labs** was co-founded by [[wiki/Mikhail Shapiro|Mikhail Shapiro]]. - **Merge Labs** was co-founded by [[wiki/Tyson Aflalo|Tyson Aflalo]]. - **Merge Labs** was co-founded by [[wiki/Sumner Norman|Sumner Norman]]. - **Merge Labs** was co-founded by [[wiki/Alex Blania|Alex Blania]]. Technology entrepreneur. - **Merge Labs** was co-founded by [[wiki/Sandro Herbig|Sandro Herbig]]. Technology entrepreneur. - **Merge Labs** was co-founded by [[wiki/Sam Altman|Sam Altman]]. OpenAI source specifies personal capacity. - **Merge Labs** is a co-founder of [[wiki/Mikhail Shapiro|Mikhail Shapiro]]. - **Merge Labs** is a co-founder of [[wiki/Tyson Aflalo|Tyson Aflalo]]. - **Merge Labs** is a co-founder of [[wiki/Sumner Norman|Sumner Norman]]. - **Merge Labs** is a co-founder of [[wiki/Alex Blania|Alex Blania]]. - **Merge Labs** is a co-founder of [[wiki/Sandro Herbig|Sandro Herbig]]. - **Merge Labs** is a co-founder of [[wiki/Sam Altman|Sam Altman]]. - **Merge Labs** is associated with [[wiki/Forest Neurotech|Forest Neurotech]]. - [[wiki/Mikhail Shapiro|Mikhail Shapiro]] co-founded **Merge Labs**. - [[wiki/Tyson Aflalo|Tyson Aflalo]] co-founded **Merge Labs**. - [[wiki/Sumner Norman|Sumner Norman]] co-founded **Merge Labs**. - [[wiki/Alex Blania|Alex Blania]] co-founded **Merge Labs**. - [[wiki/Sandro Herbig|Sandro Herbig]] co-founded **Merge Labs**. - [[wiki/Sam Altman|Sam Altman]] co-founded **Merge Labs**. OpenAI specifies personal capacity. ### Key Relationships - [[wiki/OpenAI|OpenAI]] is associated with **Merge Labs**. Scientific foundation models and frontier tools. - **Merge Labs** is associated with [[wiki/Butterfly Network|Butterfly Network]]. Multi-year licensing agreement announced 2026-09-01. - **Merge Labs** is a partner of [[wiki/Butterfly Network|Butterfly Network]]. - **Merge Labs** is associated with bridge biological and artificial intelligence. OpenAI description. - **Merge Labs** is associated with [[wiki/biology, devices and AI for BCI|biology, devices and AI for BCI]]. ### Additional Documented Relationships - The technical comparison identifies a convergence: **Merge Labs** provides a technical overlay for [[wiki/Subsense BCI|Subsense BCI]]. Both seek high-bandwidth. less-invasive molecular/material-mediated interfaces. transduction differs: ultrasound/biology emphasis versus plasmonic+MENP nanoparticle bioplatform.  ## Read First in the Wiki  - [[wiki/Neural Interfaces and Continuity Architecture|Neural Interfaces and Continuity Architecture]] — supplies the related technology, method, or technical system context needed to place **Merge Labs** within the wider system. - [[wiki/OpenAI|OpenAI]] — supplies the related organization or institution context needed to place **Merge Labs** within the wider system.  ## Related Work in the Corpus  - In [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]], **I. The week the future became a specification** provides the narrative context for **Merge Labs**: In the eight days preceding this revision, the following became public record. - In [[articles/The Next Interface Layer|The Next Interface Layer]], **The Next Interface Layer** provides the narrative context for **Merge Labs**: Most discussions of the next interface layer remain trapped at the level of product rumor: glasses, pins, pendants, earbuds, life-loggers, ambient assistants. - In [[articles/The Next Interface Layer|The Next Interface Layer]], **From Environmental Feedback to Cortical Access** provides the narrative context for **Merge Labs**: This document tracks what happens when that architecture encounters new substrates: generative AI capable of adaptive symbolic production and world simulation (OpenAI / Sora / the successor codenamed "Spud"); sovereign-scale… - In [[articles/The Next Interface Layer|The Next Interface Layer]], **Merge Labs: OpenAI's BCI Investment** provides the narrative context for **Merge Labs**: On January 15, 2026, OpenAI led a seed round for Merge Labs — reported by Bloomberg at $252 million and by TechCrunch at $250 million, at a reported valuation of approximately $850 million — with Sam Altman participating in a… - In [[articles/The Next Interface Layer|The Next Interface Layer]], **From Goggles to Cortex: Why the Leap Is Engineering, Not Fantasy** provides the narrative context for **Merge Labs**: The downstream layer is simulation, training, and operational interface architecture, which is where Lockheed Martin Orlando, Training and Logistics Solutions (TLS), Advanced Technology Laboratories, Team Orlando, the National…  ## Research Edges  #### Master relationship graph patch — 2026-09-10 **Collection:** [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Neurotechnology Ecosystem Relationship Graph - 2026-09-10|Neurotechnology Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 210 — `co_founded_by` → [[wiki/Mikhail Shapiro|Mikhail Shapiro]]** — **VERIFIED**; evidence `MERGE_OPENAI`. Research founder. - **Edge 211 — `co_founded_by` → [[wiki/Tyson Aflalo|Tyson Aflalo]]** — **VERIFIED**; evidence `MERGE_OPENAI`. Research founder. - **Edge 212 — `co_founded_by` → [[wiki/Sumner Norman|Sumner Norman]]** — **VERIFIED**; evidence `MERGE_OPENAI`. Research founder. - **Edge 213 — `co_founded_by` → [[wiki/Alex Blania|Alex Blania]]** — **VERIFIED**; evidence `MERGE_OPENAI`, `MERGE_BUTTERFLY`. Technology entrepreneur. - **Edge 214 — `co_founded_by` → [[wiki/Sandro Herbig|Sandro Herbig]]** — **VERIFIED**; evidence `MERGE_OPENAI`, `MERGE_BUTTERFLY`. Technology entrepreneur. - **Edge 215 — `co_founded_by` → [[wiki/Sam Altman|Sam Altman]]** — **VERIFIED**; evidence `MERGE_OPENAI`, `MERGE_BUTTERFLY`. OpenAI source specifies personal capacity. - **Edge 218 — `research_strategy` → biology + devices + AI** — **VERIFIED**; evidence `MERGE_OPENAI`. Core architecture. - **Edge 219 — `partners_with` → [[wiki/Butterfly Network|Butterfly Network]]** — **VERIFIED**; evidence `MERGE_BUTTERFLY`. Multi-year licensing agreement announced 2026-09-01. - **Edge 220 — `licenses` → [[wiki/Poseidon Family Ultrasound-on-Chip|Butterfly Poseidon Family Ultrasound-on-Chip]]** — **VERIFIED**; evidence `MERGE_BUTTERFLY`. For ultrasound-based BCI R&D. - **Edge 222 — `technical_overlay` → DARPA N3 acoustic/ultrasound branch** — **STRONG_TECHNICAL_CONVERGENCE**; evidence `MERGE_BUTTERFLY`, `DARPA_N3`. N3 explored focused ultrasound, acousto-optical, and acousto-magnetic routes years before Merge’s commercial stack. - **Edge 223 — `technical_overlay` → [[wiki/Subsense BCI|Subsense]]** — **STRONG_TECHNICAL_CONVERGENCE**; evidence `MERGE_OPENAI`, `SUB_TECH`. Both seek high-bandwidth, less-invasive molecular/material-mediated interfaces; transduction differs: ultrasound/biology emphasis versus plasmonic+MENP nanoparticle bioplatform. - **Edge 264 — `inherits_research_neighborhood` → Forest/Arbor ultrasound neurotechnology** — **VERIFIED**; evidence `FOREST_MERGE`, `ARBOR_TECH`. Direct organizational/research roots, stronger than generic technical convergence. #### Incoming typed edges - **Edge 216 — [[wiki/OpenAI|OpenAI]] `invested_in` → this entry** — **VERIFIED**; evidence `MERGE_OPENAI`. Seed-round participation and scientific collaboration. - **Edge 217 — [[wiki/OpenAI|OpenAI]] `collaborates_with` → this entry** — **VERIFIED**; evidence `MERGE_OPENAI`. Scientific foundation models and frontier tools. - **Edge 259 — [[wiki/Forest Neurotech|Forest Neurotech]] `research_lineage_to` → this entry** — **VERIFIED**; evidence `FOREST_MERGE`. Convergent/Essential Technology announcement states Merge team and direction have roots in Forest and the organizations will continue to partner. - **Edge 410 — [[wiki/Less-Invasive Brain-Computer Interface|less-invasive BCI]] `bridge_entities` → this entry** — **ANALYTIC**; evidence `SYNCHRON_TECH`, `SUB_TECH`, `MERGE_OPENAI`, `PRECISION_VISION`. Different access geometries solving common surgery/bandwidth trade-space.   #### Interface and soft-sovereignty graph patch — 2026-09-10 **Collections:** [[collections/War With Empire|War With Empire]] · [[collections/Neurotech|Neurotech]] **Relationship source:** [[research/Interface and Soft Sovereignty Ecosystem Relationship Graph - 2026-09-10|Interface and Soft Sovereignty Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/The Next Interface Layer|The Next Interface Layer]] · [[articles/The Magic Kingdom and the Managed State|The Magic Kingdom and the Managed State]] #### Outgoing typed edges - **Edge 508 — `co_founder` → [[wiki/Mikhail Shapiro|Mikhail Shapiro]]** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 509 — `co_founder` → [[wiki/Tyson Aflalo|Tyson Aflalo]]** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 510 — `co_founder` → [[wiki/Sumner Norman|Sumner Norman]]** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 511 — `co_founder` → [[wiki/Alex Blania|Alex Blania]]** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 512 — `co_founder` → [[wiki/Sandro Herbig|Sandro Herbig]]** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 513 — `co_founder` → [[wiki/Sam Altman|Sam Altman]]** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 514 — `seed_investor` → [[wiki/OpenAI|OpenAI]]** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 517 — `technical_strategy` → biology + devices + AI** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 518 — `technical_strategy` → [[wiki/molecular neural interfaces|molecular neural interfaces]]** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 519 — `technical_strategy` → [[wiki/deep-reaching modalities including ultrasound|deep-reaching modalities including ultrasound]]** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 534 — `personnel_lineage_from` → [[wiki/Forest Neurotech|Forest Neurotech]]** — **STRONG_TECHNICAL_LINEAGE**; evidence `OPENAI_MERGE`, `ARBOR_ABOUT`. Aflalo and Norman are common founders; do not describe Merge as corporate successor unless a source says so. - **Edge 535 — `licensed` → [[wiki/Poseidon Family Ultrasound-on-Chip|Butterfly Poseidon Family of Ultrasound-on-Chip]]** — **VERIFIED**; evidence `BUTTERFLY_MERGE`. - **Edge 536 — `partner` → [[wiki/Butterfly Network|Butterfly Network]]** — **VERIFIED**; evidence `BUTTERFLY_MERGE`. #### Incoming typed edges - **Edge 515 — [[wiki/OpenAI|OpenAI]] `collaborates_with` → this entry** — **VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 542 — [[wiki/MOANA|MOANA]] `technical_convergence_with` → this entry** — **STRONG_STRUCTURAL_CONVERGENCE**; evidence `RICE_MOANA`, `OPENAI_MERGE`, `BUTTERFLY_MERGE`. Both pursue lower-invasiveness deep neural access; modalities differ in detail. - **Edge 575 — [[wiki/neural access|neural access]] `exemplar` → this entry** — **CORPUS_I**; evidence `CORPUS_NEXT`.   #### Consciousness mapping and transfer graph patch — 2026-09-10 **Collections:** [[collections/Neurotech|Neurotech]] · [[collections/Consciousness Continuity|Consciousness Continuity]] **Relationship source:** [[research/Consciousness Mapping and Transfer Ecosystem Relationship Graph - 2026-09-10|Consciousness Mapping and Transfer Ecosystem Relationship Graph — 2026-09-10]] **Related source articles:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] · [[articles/The Architecture of Continuity and Emerging Neuroinformatics Standards|The Architecture of Continuity and Emerging Neuroinformatics Standards]] · [[articles/2026 Annual Report on Brain-Computer Interfaces|2026 Annual Report on Brain-Computer Interfaces]] · [[articles/The Organic-Synthetic Brain Atlas|The Organic-Synthetic Brain Atlas]] #### Outgoing typed edges - **Edge 210 — `co_founded_by` → [[wiki/Mikhail Shapiro|Mikhail Shapiro]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MERGE_OPENAI`. Research founder. - **Edge 211 — `co_founded_by` → [[wiki/Tyson Aflalo|Tyson Aflalo]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MERGE_OPENAI`. Research founder. - **Edge 212 — `co_founded_by` → [[wiki/Sumner Norman|Sumner Norman]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MERGE_OPENAI`. Research founder. - **Edge 213 — `co_founded_by` → [[wiki/Alex Blania|Alex Blania]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MERGE_OPENAI`, `MERGE_BUTTERFLY`. Technology entrepreneur. - **Edge 214 — `co_founded_by` → [[wiki/Sandro Herbig|Sandro Herbig]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MERGE_OPENAI`, `MERGE_BUTTERFLY`. Technology entrepreneur. - **Edge 215 — `co_founded_by` → [[wiki/Sam Altman|Sam Altman]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MERGE_OPENAI`, `MERGE_BUTTERFLY`. OpenAI source specifies personal capacity. - **Edge 218 — `research_strategy` → biology + devices + AI** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MERGE_OPENAI`. Core architecture. - **Edge 219 — `partners_with` → [[wiki/Butterfly Network|Butterfly Network]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MERGE_BUTTERFLY`. Multi-year licensing agreement announced 2026-09-01. - **Edge 220 — `licenses` → [[wiki/Butterfly Poseidon Family Ultrasound-on-Chip|Butterfly Poseidon Family Ultrasound-on-Chip]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `MERGE_BUTTERFLY`. For ultrasound-based BCI R&D. - **Edge 222 — `technical_overlay` → [[wiki/DARPA N3 acoustic and ultrasound branch|DARPA N3 acoustic/ultrasound branch]]** — **PRIOR_NEUROTECH_STRONG_TECHNICAL_CONVERGENCE**; evidence `MERGE_BUTTERFLY`, `DARPA_N3`. N3 explored focused ultrasound, acousto-optical, and acousto-magnetic routes years before Merge’s commercial stack. - **Edge 223 — `technical_overlay` → [[wiki/Subsense BCI|Subsense]]** — **PRIOR_NEUROTECH_STRONG_TECHNICAL_CONVERGENCE**; evidence `MERGE_OPENAI`, `SUB_TECH`. Both seek high-bandwidth, less-invasive molecular/material-mediated interfaces; transduction differs: ultrasound/biology emphasis versus plasmonic+MENP nanoparticle bioplatform. - **Edge 264 — `inherits_research_neighborhood` → [[wiki/Forest and Arbor ultrasound neurotechnology|Forest/Arbor ultrasound neurotechnology]]** — **PRIOR_NEUROTECH_VERIFIED**; evidence `FOREST_MERGE`, `ARBOR_TECH`. Direct organizational/research roots, stronger than generic technical convergence. - **Edge 551 — `co_founder` → [[wiki/Mikhail Shapiro|Mikhail Shapiro]]** — **PRIOR_INTERFACE_VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 552 — `co_founder` → [[wiki/Tyson Aflalo|Tyson Aflalo]]** — **PRIOR_INTERFACE_VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 553 — `co_founder` → [[wiki/Sumner Norman|Sumner Norman]]** — **PRIOR_INTERFACE_VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 554 — `co_founder` → [[wiki/Alex Blania|Alex Blania]]** — **PRIOR_INTERFACE_VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 555 — `co_founder` → [[wiki/Sandro Herbig|Sandro Herbig]]** — **PRIOR_INTERFACE_VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 556 — `co_founder` → [[wiki/Sam Altman|Sam Altman]]** — **PRIOR_INTERFACE_VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 557 — `seed_investor` → [[wiki/OpenAI|OpenAI]]** — **PRIOR_INTERFACE_VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 559 — `technical_strategy` → biology + devices + AI** — **PRIOR_INTERFACE_VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 560 — `technical_strategy` → molecular neural interfaces** — **PRIOR_INTERFACE_VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 561 — `technical_strategy` → deep-reaching modalities including ultrasound** — **PRIOR_INTERFACE_VERIFIED**; evidence `OPENAI_MERGE`. - **Edge 572 — `personnel_lineage_from` → [[wiki/Forest Neurotech|Forest Neurotech]]** — **PRIOR_INTERFACE_STRONG_TECHNICAL_LINEAGE**; evidence `OPENAI_MERGE`, `ARBOR_ABOUT`. Aflalo and Norman are common founders; do not describe Merge as corporate successor unless a source says so. - **Edge 573 — `licensed` → [[wiki/Poseidon Family Ultrasound-on-Chip|Butterfly Poseidon Family of Ultrasound-on-Chip]]** — **PRIOR_INTERFACE_VERIFIED**; evidence `BUTTERFLY_MERGE`. - **Edge 574 — `partner` → [[wiki/Butterfly Network|Butterfly Network]]** — **PRIOR_INTERFACE_VERIFIED**; evidence `BUTTERFLY_MERGE`. - **Edge 680 — `mission` → bridge biological and artificial intelligence** — **VERIFIED_PRIMARY**; evidence `OPENAI_MERGE_CURRENT`. OpenAI description. - **Edge 681 — `combines` → [[wiki/biology, devices and AI for BCI|biology, devices and AI for BCI]]** — **VERIFIED_PRIMARY**; evidence `OPENAI_MERGE_CURRENT`. - **Edge 688 — `licensed` → [[wiki/Butterfly Poseidon Ultrasound-on-Chip|Butterfly Poseidon Ultrasound-on-Chip]]** — **VERIFIED_PRIMARY**; evidence `BUTTERFLY_MERGE_CURRENT`. Multi-year BCI R&D agreement announced Sep 1 2026. #### Incoming typed edges - **Edge 216 — [[wiki/OpenAI|OpenAI]] `invested_in` → this entry** — **VERIFIED_PRIMARY**; evidence `MERGE_OPENAI`, `OPENAI_MERGE_CURRENT`. Seed-round participation and scientific collaboration. Seed round announced Jan 15 2026. - **Edge 217 — [[wiki/OpenAI|OpenAI]] `collaborates_with` → this entry** — **VERIFIED_PRIMARY**; evidence `MERGE_OPENAI`, `OPENAI_MERGE`, `OPENAI_MERGE_CURRENT`. Scientific foundation models and frontier tools. - **Edge 259 — [[wiki/Forest Neurotech|Forest Neurotech]] `research_lineage_to` → this entry** — **PRIOR_NEUROTECH_VERIFIED**; evidence `FOREST_MERGE`. Convergent/Essential Technology announcement states Merge team and direction have roots in Forest and the organizations will continue to partner. - **Edge 580 — [[wiki/MOANA|MOANA]] `technical_convergence_with` → this entry** — **PRIOR_INTERFACE_STRONG_STRUCTURAL_CONVERGENCE**; evidence `RICE_MOANA`, `OPENAI_MERGE`, `BUTTERFLY_MERGE`. Both pursue lower-invasiveness deep neural access; modalities differ in detail. - **Edge 598 — [[wiki/neural access|neural access]] `exemplar` → this entry** — **PRIOR_INTERFACE_CORPUS_I**; evidence `CORPUS_NEXT`. - **Edge 682 — [[wiki/Mikhail Shapiro|Mikhail Shapiro]] `co_founded` → this entry** — **VERIFIED_PRIMARY**; evidence `OPENAI_MERGE_CURRENT`. - **Edge 683 — [[wiki/Tyson Aflalo|Tyson Aflalo]] `co_founded` → this entry** — **VERIFIED_PRIMARY**; evidence `OPENAI_MERGE_CURRENT`. - **Edge 684 — [[wiki/Sumner Norman|Sumner Norman]] `co_founded` → this entry** — **VERIFIED_PRIMARY**; evidence `OPENAI_MERGE_CURRENT`. - **Edge 685 — [[wiki/Alex Blania|Alex Blania]] `co_founded` → this entry** — **VERIFIED_PRIMARY**; evidence `OPENAI_MERGE_CURRENT`. - **Edge 686 — [[wiki/Sandro Herbig|Sandro Herbig]] `co_founded` → this entry** — **VERIFIED_PRIMARY**; evidence `OPENAI_MERGE_CURRENT`. - **Edge 687 — [[wiki/Sam Altman|Sam Altman]] `co_founded` → this entry** — **VERIFIED_PRIMARY**; evidence `OPENAI_MERGE_CURRENT`. OpenAI specifies personal capacity.   #### Host–residual infrastructure patch — 2026-09-10 **Collections:** [[collections/Consciousness Continuity|Consciousness Continuity]] · [[collections/Neurotech|Neurotech]] · [[collections/Machine Succession|Machine Succession]] **Canonical source article:** [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]] **Related acquisition source:** [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] **Relationship source:** [[research/Mind Uploading and AI Host-Residual Ecosystem Relationship Graph - 2026-09-10|Mind Uploading and AI Host-Residual Ecosystem Relationship Graph — 2026-09-10]] #### Outgoing typed edges - **HR-0246 — `develops` → `BCIs combining biology, devices and AI`** — **VERIFIED EXTERNAL**; evidence `WEB_OPENAI_MERGE`. Company mission as described by OpenAI. - **HR-0778 — `wiki_links_to` → [[wiki/Neural Interfaces and Continuity Architecture|Neural Interfaces and Continuity Architecture]]** — **EXISTING WIKI EDGE**; evidence `WIKI_ARCHIVE`. Direct internal link currently present in `Merge Labs.md`. - **HR-0779 — `wiki_links_to` → [[wiki/OpenAI|OpenAI]]** — **EXISTING WIKI EDGE**; evidence `WIKI_ARCHIVE`. Direct internal link currently present in `Merge Labs.md`. #### Incoming typed edges - **HR-0244 — [[wiki/OpenAI|OpenAI]] `invests_in` → this entry** — **VERIFIED EXTERNAL**; evidence `WEB_OPENAI_MERGE`. Seed-round participation. - **HR-0824 — [[wiki/Neural Interfaces and Continuity Architecture|Neural Interfaces and Continuity Architecture]] `wiki_links_to` → this entry** — **EXISTING WIKI EDGE**; evidence `WIKI_ARCHIVE`. Direct internal link currently present in `Neural Interfaces and Continuity Architecture.md`. - **HR-0858 — [[wiki/OpenAI|OpenAI]] `wiki_links_to` → this entry** — **EXISTING WIKI EDGE**; evidence `WIKI_ARCHIVE`. Direct internal link currently present in `OpenAI.md`.  ## Research Inferences  These entries translate the forward-looking register in [[research/Research Inferences|Research Inferences]] into ordinary wiki prose. The tier labels apply to the inference, not automatically to every factual anchor inside it. The interpretive frame comes from [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0026 — Strongly indicated.** Merge Labs joins ultrasound hardware from Forest Neurotech to Mikhail Shapiro's acoustic-biomolecular line at Caltech, which is the first time the field half and the receptor half of a field-addressed interface have been capitalized inside one company. The composite — sensitize, then address — is what removes surgery from the bandwidth equation.  ## Research Inference Attractors  These are secondary semantic placements for the inference attractor network. Each statement keeps its original ID and tier; its canonical cluster page links back to every destination. Source register: [[research/Research Inferences|Research Inferences]]. Interpretive context: [[articles/Technologies for Consciousness Mapping and Transfer|Technologies for Consciousness Mapping and Transfer]] and [[articles/Mind Uploading and AI — The Host is Reusable and the Person is the Delta|Mind Uploading and AI — The Host is Reusable and the Person is the Delta]]. Collection route: [[collections/Neurotech|Neurotech]]. - **INF-0027 — Established.** Sonogenetics works by installing mechanosensitive channels so that acoustic pressure becomes an ionic event in a chosen cell population. Selectivity is therefore a genetic property and focality an acoustic one, and the two can be improved independently, which is why this architecture scales differently from electrodes. - **Canonical cluster:** [[wiki/molecular neural interfaces|molecular neural interfaces]] - **INF-0028 — Strongly indicated.** A magnetostrictive core inside a piezoelectric shell converts a magnetic field that passes the skull unattenuated into a local electric field that neurons answer. The particle is a field translator, and its existence means depth access does not require a hole — it requires distribution. - **Canonical cluster:** [[wiki/molecular neural interfaces|molecular neural interfaces]] - **INF-0031 — Plausible.** Every molecular interface requires a delivery vector, which makes AAV capsid engineering an interface technology rather than a gene-therapy technology. Capsid tropism determines which cells can be addressed, so the vector library is functionally the addressing scheme of the future nervous-system network. - **Canonical cluster:** [[wiki/molecular neural interfaces|molecular neural interfaces]] - **INF-0034 — Plausible.** A one-time sensitizing edit followed by a lifetime of external field addressing inverts the economics of neural interfacing: the expensive, risky step happens once and the hardware upgrades stay outside the body. This is the configuration most likely to reach populations rather than patients. - **Canonical cluster:** [[wiki/molecular neural interfaces|molecular neural interfaces]] - **INF-0035 — Plausible.** Nanoscale devices inside tissue need a communication layer, and molecular and terahertz channels are the two candidates with the right length scales. The body-internal network is being specified now in exactly the way IP was specified before there was traffic to carry. - **Canonical cluster:** [[wiki/molecular neural interfaces|molecular neural interfaces]] - **INF-0039 — Plausible.** Field-plus-receptor architectures make addressable population size a function of expression pattern rather than of implant geometry. If expression can be driven across a cortical region, the addressable channel count jumps by orders of magnitude in a single step rather than by iterative device generations. - **Canonical cluster:** [[wiki/molecular neural interfaces|molecular neural interfaces]] - **INF-0042 — Strongly indicated.** A non-surgical read/write channel and a high-fidelity world model are complementary halves of the same product: one supplies the environment, the other the participant. The teams pursuing them are already capitalized by the same investor set, which shortens the integration timeline considerably. - **Canonical cluster:** [[wiki/molecular neural interfaces|molecular neural interfaces]] - **INF-0043 — Established.** Shapiro's acoustic biomolecules moving from a Caltech laboratory into a venture-backed company with OpenAI as research collaborator is a complete technology-transfer event with a named date. Trace the researcher and the capability's location is always known. - **Canonical cluster:** [[wiki/molecular neural interfaces|molecular neural interfaces]] - **INF-0048 — Plausible.** As modalities multiply, the durable asset stops being the transducer and becomes the signal format and the model that consumes it. Whoever defines the representation that all modalities target owns the layer above every device generation. - **Canonical cluster:** [[wiki/molecular neural interfaces|molecular neural interfaces]] - **INF-0050 — Plausible.** If the receptor layer is genetic and the field layer is external, the interface upgrades on a hardware cadence while the biological substrate stays constant. That is the first architecture in neurotechnology with a Moore's-law-shaped improvement path, because the fast-moving component is no longer inside the patient. - **Canonical cluster:** [[wiki/molecular neural interfaces|molecular neural interfaces]] - **INF-0467 — Analytic.** European rules become global operating standards because compliance is cheaper to universalize than to segment. European neural-data classification will therefore govern products sold everywhere, regardless of local law. - **Canonical cluster:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]] - **INF-0473 — Analytic.** Capabilities developed under restricted programs become publicly known years after they work, which means public visibility systematically lags actual capability. Estimating the lag from historical cases is more informative than assuming it is zero. - **Canonical cluster:** [[wiki/Neurotechnology Ecosystem|Neurotechnology Ecosystem]]